Found 82 matching trials
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
PHASE2This study evaluates the interest of regorafenib in combination of metronom...
Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors
PHASE1The study is a two-stage trial:
1. First stage (closed - 16 patients recru...
Location
Cliniques Universitaires Saint-Luc (CUSL)
Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)
PHASE2A phase II clinical trial designed to test the effect of combining endocrin...
Location
Faculty of Medicine, Cairo University
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
PHASE4This is a multi-center real-world study, in which patients who meet the inc...
Location
The Fourth Hospital of Hebei Medical University
Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
PHASE2This is a single-centre, non-randomized, open label phase II trial to be co...
Location
National Cancer Centre, Singapore
Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients
PHASE2Colorectal cancer (CRC) in Egypt is advanced tumors at diagnosis. Although,...
Location
Multiple Locations
Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer
PHASE3It is a phase III trial to explore the efficacy and safety of utidelone plu...
Capecitabine in Low Risk Triple Negative Breast Cancer
PHASE2This study aims to evaluate the efficacy and safety of capecitabine as the ...
Location
breast cancer institute of Fudan University Cancer Hospital
EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR)
PHASE2The investigators aim to investigate whether incorporating on-treatment EBV...
Location
Sun Yat-sen University Cancer Center
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
PHASE3This trial is aimed to investigate whether additional adjuvant PD-1 antibod...
Location
Sun Yat-sen University Cancer Center